SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review.
Saved in:
| Title: | SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review. |
|---|---|
| Authors: | Seidu, Samuel1 (AUTHOR), Alabraba, Vicki2 (AUTHOR), Davies, Sarah3 (AUTHOR), Newland-Jones, Philip4 (AUTHOR), Fernando, Kevin5 (AUTHOR), Bain, Stephen C.6,7 (AUTHOR), Diggle, Jane8 (AUTHOR), Evans, Marc9 (AUTHOR), James, June2 (AUTHOR), Kanumilli, Naresh10,11 (AUTHOR), Milne, Nicola10 (AUTHOR), Viljoen, Adie12 (AUTHOR), Wheeler, David C.13 (AUTHOR), Wilding, John P. H.14 (AUTHOR) j.p.h.wilding@liverpool.ac.uk |
| Source: | Diabetes Therapy. May2024, Vol. 15 Issue 5, p1099-1124. 26p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
